Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin
- Type
- Retraction
- Notice date
- 2/23/2024 0:00
- Journal
- Oncogene
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1038/s41388-024-02964-y
- Original paper DOI
- 10.1038/onc.2013.220